Senores Pharmaceuticals Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹175.19 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.48 per cent from ₹170.95 crore. This corresponds to a year-on-year *(YoY) growth of 53.39 per cent.
Operating Profit
Operating Profit stands at ₹47.49 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 5.77 per cent from ₹50.40 crore. This corresponds to a year-on-year *(YoY) growth of 144.29 per cent.
PBDT
PBDT stands at ₹56.70 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.08 per cent from ₹52.46 crore. This corresponds to a year-on-year *(YoY) growth of 118.83 per cent.
Profit Before Tax
Profit Before Tax stands at ₹47.40 crore, reflecting a quarter-on-quarter *(QoQ) increase of 6.28 per cent from ₹44.60 crore. This corresponds to a year-on-year *(YoY) growth of 129.21 per cent.
Net Profit
Net Profit stands at ₹36.67 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.20 per cent from ₹33.58 crore. This represents a 104.06 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Senores Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Senores Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Senores Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Senores Pharmaceuticals Ltd Financial Reports
Senores Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Senores Pharma. | 0.89% | 5.15% | 23.62% | 71.39% | 76.47% | 135.07% |
| Jeena Sikho | -0.12% | 4.86% | -0.47% | -10.54% | -13.52% | 9.99% |
| FDC | 0.61% | 1.01% | 14.82% | 23.29% | 9.04% | -13.29% |
| Supriya Lifesci. | -0.44% | 0.74% | -6.84% | 36.94% | 17.37% | 27.02% |
| Aarti Pharma | 0.69% | 0.01% | 13.70% | 1.90% | -6.36% | -23.73% |
| Innova Captab | -0.17% | 3.44% | 3.86% | 43.19% | 44.59% | 12.97% |
| Bliss GVS Pharma | -0.80% | 6.99% | 19.89% | 100.31% | 203.60% | 240.03% |
Company Info
Company Information
Managing Director : SWAPNIL JATINBHAI SHAH
Chairman (Non-Executive) : Sanjay Majmudar
Non Executive Director : Hemanshu Nitinchandra Pandya
Independent Director : Jitendra Babulal Sanghvi
Whole Time Director & Chief Operating Officer : Chetan Bipinchandra Shah
Whole Time Director & Chief Financial Officer : Deval Rajnikant Shah
Non Executive Director : Ashokkumar Vijaysinh Barot
Non Executive Director : ARPIT DEEPAKKUMAR SHAH
Independent Director : Naresh Bansilal Shah
Independent Director : Manjula Devi Shroff
Independent Director : Kalpit Rajesh Gandhi
Independent Director : Udayan Choksi